Search / 26 results found Showing: 1-10 of 26
In an upcoming weekend interview, Israeli Prime Minister Benjamin Netanyahu reveals that he is in talks with Pfizer and Moderna for tens of millions of doses approved for kids.
The post Netanyahu: Children under 16 likely to be vaccinated by summer appeared first on JNS.org.
Ohioans who are 60 years and older will be included in the next phase of the state’s COVID-19 vaccination process, Ohio Gov. Mike DeWine said …
Carried out by Israel’s largest HMO in cooperation with Harvard University, the study of 1.2 million people shows that the Pfizer-BioNTech vaccine is 92 percent effective in preventing serious disease.
The post Pfizer vaccine 94 percent effective at preventing symptomatic COVID-19, new study finds appeared first on JNS.org.
New Israeli research bolsters emerging evidence that Pfizer-BioNTech’s vaccine protects both those immunized and those around them.
The post Study: Even one dose of Pfizer COVID-19 vaccine lowers viral load and spread appeared first on JNS.org.
Vaccination reduces the viral load in COVID-positive individuals by as much as 20 times, indicating that vaccination may also reduce transmission, say researchers.
The post Pfizer vaccinees less likely to pass coronavirus to others, Israeli study finds appeared first on JNS.org.
“This is an emotional closure for me,” says Albert Bourla, the son of Holocaust survivors from Thessaloniki.
The post Technion to award Pfizer CEO honorary doctorate for coronavirus vaccine appeared first on JNS.org.
“This is very, very good news,” said Anat Ekka Zohar, Maccabi’s top vaccine statistics analyst.
The post In first real-world study, Pfizer vaccine shows high rate of effectiveness in Israel appeared first on JNS.org.
Experts weigh in on the Pfizer-BioNTech vaccine’s effects and how Israel got to be #1 in vaccinations per capita.
The post What the world can learn about immunity from Israel’s fast vaccine rollout appeared first on JNS.org.
According to the agreement, the MoH will provide epidemiological info to the pharmaceutical giant in exchange for the ongoing delivery of the BioNTech COVID-19 vaccine.
The post Israeli Health Ministry publishes data-sharing contract inked with Pfizer appeared first on JNS.org.
The Clalit Health Fund study, which involved the testing of 200,000 Israelis aged 60 and up, are in line with the pharmaceutical giant’s own research.
The post One dose of Pfizer’s vaccine cuts infection rate by a third after two weeks, Israeli study finds appeared first on JNS.org.
